Replies to post #96386 on Ayala Pharmaceuticals Inc (ADXS)

[James salmon]

I believe Hov posted something on that earlier, and it pretty clear that combo OS is significantly better that Keytruda alone, from previous Keytruda trials.

Big difficulty is when you look at the patient population on each trial. We know that Advaxis normally has the sickest of the sickest in its trials.